Schizoaffective Disorders Completed Phase 4 Trials for Pravastatin (DB00175)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01082588Effects of Pravastatin on Cholesterol, Inflammation and Cognition in SchizophreniaTreatment
NCT00177580Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With PravastatinTreatment